Skip to content

Evaluation of a Smartphone Based Optical Diagnostic Tool for Neonatal Jaundice

Evaluation of a Smartphone Based Optical Diagnostic Tool for Neonatal Jaundice

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03007563
Enrollment
342
Registered
2017-01-02
Start date
2017-01-31
Completion date
2019-03-15
Last updated
2020-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperbilirubinemia, Neonatal, Jaundice, Neonatal

Keywords

Diagnosis, Cell Phones, Infant, Newborn

Brief summary

Neonatal jaundice is a common and most often harmless condition. However, when unrecognized it can be fatal or cause serious brain injury. Three quarters of these deaths are estimated to occur in the poorest regions of the world. The treatment of jaundice, phototherapy, is in most cases easy, low-cost and harmless. The crucial point in reducing the burden of disease is therefore to identify then children at risk. This results in the need for low-cost, reliable and easy-to-use diagnostic tools that can identify newborns with jaundice. Based on previous research on the bio-optics of jaundiced newborn skin, a prototype of a smartphone application has been developed. This prototype will be evaluated in a clinical trial in two hospitals in Norway. A smartphone will be used to take picture of the skin of the newborn, and by using an algorithm an estimate of the bilirubin concentration is made. The results from these estimates will be compared to the bilirubin levels measured in standard blood samples, as well as the results from ordinary transcutaneous measurement devices.

Interventions

DEVICEbilirubin concentration estimation from smartphone pictures

pictures taken of the skin covering the breast bone

DEVICEbilirubin concentration measured by transcutaneous device

Sponsors

Norwegian University of Science and Technology
CollaboratorOTHER
University Hospital, Akershus
CollaboratorOTHER
St. Olavs Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Days to 14 Days
Healthy volunteers
No

Inclusion criteria

* born in St.Olavs hospital, Trondheim or in Akershus hospital, Oslo, Norway * born at term * normal birth weight

Exclusion criteria

* in need of advanced medical treatment

Design outcomes

Primary

MeasureTime frameDescription
Correlation between bilirubin estimates by smartphone pictures and by blood samples5 minutesEstimate of bilirubin levels from smartphone pictures, compared with bilirubin measurement in blood samples in a correlation study. Correlation will be expressed by Pearson correlation coefficient, r.
Correlation between bilirubin estimates by smartphone pictures and by transcutaneous measurements5 minutesEstimate of bilirubin levels from smartphone pictures, compared with bilirubin measurements from transcutaneous devices in a correlation study. Correlation will be expressed by Pearson correlation coefficient, r.

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026